188 related articles for article (PubMed ID: 20735426)
1. Cis-isomerism and other chemical requirements of steroidal agonists and partial agonists acting at TRPM3 channels.
Majeed Y; Agarwal AK; Naylor J; Seymour VA; Jiang S; Muraki K; Fishwick CW; Beech DJ
Br J Pharmacol; 2010 Sep; 161(2):430-41. PubMed ID: 20735426
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels.
Drews A; Mohr F; Rizun O; Wagner TF; Dembla S; Rudolph S; Lambert S; Konrad M; Philipp SE; Behrendt M; Marchais-Oberwinkler S; Covey DF; Oberwinkler J
Br J Pharmacol; 2014 Feb; 171(4):1019-32. PubMed ID: 24251620
[TBL] [Abstract][Full Text] [Related]
3. Pregnenolone sulphate-independent inhibition of TRPM3 channels by progesterone.
Majeed Y; Tumova S; Green BL; Seymour VA; Woods DM; Agarwal AK; Naylor J; Jiang S; Picton HM; Porter KE; O'Regan DJ; Muraki K; Fishwick CW; Beech DJ
Cell Calcium; 2012 Jan; 51(1):1-11. PubMed ID: 22000496
[TBL] [Abstract][Full Text] [Related]
4. Activation of steroid-sensitive TRPM3 channels potentiates glutamatergic transmission at cerebellar Purkinje neurons from developing rats.
Zamudio-Bulcock PA; Everett J; Harteneck C; Valenzuela CF
J Neurochem; 2011 Nov; 119(3):474-85. PubMed ID: 21955047
[TBL] [Abstract][Full Text] [Related]
5. Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction.
Naylor J; Li J; Milligan CJ; Zeng F; Sukumar P; Hou B; Sedo A; Yuldasheva N; Majeed Y; Beri D; Jiang S; Seymour VA; McKeown L; Kumar B; Harteneck C; O'Regan D; Wheatcroft SB; Kearney MT; Jones C; Porter KE; Beech DJ
Circ Res; 2010 May; 106(9):1507-15. PubMed ID: 20360246
[TBL] [Abstract][Full Text] [Related]
6. Partial Agonistic Actions of Sex Hormone Steroids on TRPM3 Function.
Persoons E; Kerselaers S; Voets T; Vriens J; Held K
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948452
[TBL] [Abstract][Full Text] [Related]
7. TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan.
Ciurtin C; Majeed Y; Naylor J; Sukumar P; English AA; Emery P; Beech DJ
BMC Musculoskelet Disord; 2010 Jun; 11():111. PubMed ID: 20525329
[TBL] [Abstract][Full Text] [Related]
8. Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3.
Straub I; Mohr F; Stab J; Konrad M; Philipp SE; Oberwinkler J; Schaefer M
Br J Pharmacol; 2013 Apr; 168(8):1835-50. PubMed ID: 23190005
[TBL] [Abstract][Full Text] [Related]
9. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
[TBL] [Abstract][Full Text] [Related]
10. Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids.
Majeed Y; Amer MS; Agarwal AK; McKeown L; Porter KE; O'Regan DJ; Naylor J; Fishwick CW; Muraki K; Beech DJ
Br J Pharmacol; 2011 Apr; 162(7):1509-20. PubMed ID: 21108630
[TBL] [Abstract][Full Text] [Related]
11. Disease-associated mutations in the human TRPM3 render the channel overactive via two distinct mechanisms.
Zhao S; Yudin Y; Rohacs T
Elife; 2020 Apr; 9():. PubMed ID: 32343227
[TBL] [Abstract][Full Text] [Related]
12. Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo.
Straub I; Krügel U; Mohr F; Teichert J; Rizun O; Konrad M; Oberwinkler J; Schaefer M
Mol Pharmacol; 2013 Nov; 84(5):736-50. PubMed ID: 24006495
[TBL] [Abstract][Full Text] [Related]
13. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Transient Receptor Potential Melastatin 3 ion channels by G-protein βγ subunits.
Badheka D; Yudin Y; Borbiro I; Hartle CM; Yazici A; Mirshahi T; Rohacs T
Elife; 2017 Aug; 6():. PubMed ID: 28829742
[TBL] [Abstract][Full Text] [Related]
15. Activation and inhibition of transient receptor potential TRPM3-induced gene transcription.
Lesch A; Rubil S; Thiel G
Br J Pharmacol; 2014 May; 171(10):2645-58. PubMed ID: 24895737
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Steroid Activation of TRPM3 on Spontaneous Activity in the Developing Retina.
Webster CM; Tworig J; Caval-Holme F; Morgans CW; Feller MB
eNeuro; 2020; 7(2):. PubMed ID: 32238415
[TBL] [Abstract][Full Text] [Related]
17. Control of TRPM3 Ion Channels by Protein Kinase CK2-Mediated Phosphorylation in Pancreatic β-Cells of the Line INS-1.
Becker A; Götz C; Montenarh M; Philipp SE
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884938
[TBL] [Abstract][Full Text] [Related]
18. Primidone inhibits TRPM3 and attenuates thermal nociception in vivo.
Krügel U; Straub I; Beckmann H; Schaefer M
Pain; 2017 May; 158(5):856-867. PubMed ID: 28106668
[TBL] [Abstract][Full Text] [Related]
19. Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
Front Immunol; 2019; 10():2545. PubMed ID: 31736966
[TBL] [Abstract][Full Text] [Related]
20. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.
Nguyen T; Johnston S; Clarke L; Smith P; Staines D; Marshall-Gradisnik S
Clin Exp Immunol; 2017 Feb; 187(2):284-293. PubMed ID: 27727448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
